Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Donehower

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignanciesJ Gilbert, S D Baker, M K Bowling, et al.
Cancer|March 26, 1999
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinomaB Mikhak, M Zahurak, M D Abeloff, et al.
Urology|December 22, 1999
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumorsJ B Nelson, R N Chen, J T Bishoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agentE K Rowinsky, G S Long, D A Noe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2008
Phase I study of troxacitabine administered by continuous infusion in subjects with advanced solid malignanciesA Jimeno, W A Messersmith, C K Lee, et al.
Annals of Internal Medicine|August 15, 1989
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasmsW P McGuire, E K Rowinsky, N B Rosenshein, et al.
Medical and Pediatric Oncology|January 1, 1989
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group studyD S Ettinger, D M Finkelstein, R C Donehower, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancerM J Kennedy, M L Zahurak, R C Donehower, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumorsS O'Reilly, L B Grochow, R C Donehower, et al.
Journal of the National Cancer Institute|December 7, 1988
Clinical and pharmacologic reappraisal of dichloromethotrexateA Hantel, E K Rowinsky, D A Noe, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignanciesJ Gilbert, S D Baker, M K Bowling, et al.
Cancer|March 26, 1999
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinomaB Mikhak, M Zahurak, M D Abeloff, et al.
Urology|December 22, 1999
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumorsJ B Nelson, R N Chen, J T Bishoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agentE K Rowinsky, G S Long, D A Noe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2008
Phase I study of troxacitabine administered by continuous infusion in subjects with advanced solid malignanciesA Jimeno, W A Messersmith, C K Lee, et al.
Annals of Internal Medicine|August 15, 1989
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasmsW P McGuire, E K Rowinsky, N B Rosenshein, et al.
Medical and Pediatric Oncology|January 1, 1989
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group studyD S Ettinger, D M Finkelstein, R C Donehower, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancerM J Kennedy, M L Zahurak, R C Donehower, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumorsS O'Reilly, L B Grochow, R C Donehower, et al.
Journal of the National Cancer Institute|December 7, 1988
Clinical and pharmacologic reappraisal of dichloromethotrexateA Hantel, E K Rowinsky, D A Noe, et al.
Pageof 13